These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26184092)

  • 21. Dysautonomia and hyponatraemia as harbingers of Guillain-Barre syndrome.
    Shah PM; Dhakre VW; Veerasuri R; Bhabhor A
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30992282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age may contribute to the increased frequency of axonal Guillain-Barré syndrome.
    Hawkes MA; Wilken M; Vázquez G; Farez MF
    Muscle Nerve; 2017 Dec; 56(6):1171-1173. PubMed ID: 28467012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study.
    Khedr EM; Mahmoud DM; Ahmed GK; Haridy NA
    Clin Neurol Neurosurg; 2023 Dec; 235():108026. PubMed ID: 37913589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guillain-Barré syndrome in the elderly.
    Peric S; Berisavac I; Stojiljkovic Tamas O; Rajic S; Babic M; Cvijanovic M; Dominovic-Kovacevic A; Basta I; Beslac-Bumbasirevic L; Lavrnic D
    J Peripher Nerv Syst; 2016 Jun; 21(2):105-10. PubMed ID: 26880714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features of Guillain-Barré Syndrome in a tertiary-level hospital in Mexico].
    Carrera-Pineda R; Gutiérrez-Casillas S; Amaya-Sánchez LE; Tafoya-Arellano G; Aguilar-Castillo S; Martínez-Marino M; Villamil-Osorio LV; Guerrero-Cantera J
    Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 4):S419-S424. PubMed ID: 29799712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.
    Yamagishi Y; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida K; Ikeda SI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
    J Peripher Nerv Syst; 2017 Dec; 22(4):433-439. PubMed ID: 28833828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients.
    Tan CY; Razali SNO; Goh KJ; Shahrizaila N
    J Peripher Nerv Syst; 2019 Jun; 24(2):168-173. PubMed ID: 31001904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome.
    Wen P; Wang L; Liu H; Gong L; Ji H; Wu H; Chu W
    Sci Rep; 2021 Jun; 11(1):11578. PubMed ID: 34079013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal salt wasting as part of dysautonomia in Guillain-Barre syndrome.
    Lenhard T; Grimm C; Ringleb PA
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1051-3. PubMed ID: 20732865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for respiratory failure among hospitalized patients with Guillain-Barré syndrome.
    Maskin LP; Wilken M; Rodriguez Lucci F; Wisnivesky JP; Barroso F; Wainsztein N
    Neurologia (Engl Ed); 2024; 39(1):36-42. PubMed ID: 38161071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and outcomes of patients with Guillain-Barré and acquired CNS demyelinating overlap syndrome: a cohort study based on a literature review.
    Mao Z; Hu X
    Neurol Res; 2014 Dec; 36(12):1106-13. PubMed ID: 24914906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of autonomic dysfunction in hospitalized patients with Guillain-Barré syndrome.
    Anandan C; Khuder SA; Koffman BM
    Muscle Nerve; 2017 Aug; 56(2):331-333. PubMed ID: 28039863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between serum low-density neutrophils and acute-onset and recurrent Guillain-Barré syndrome.
    Ren K; Yang A; Lu J; Zhao D; Bai M; Ding J; Wei T; Li H; Guo J
    Brain Behav; 2022 Jan; 12(1):e2456. PubMed ID: 34894104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality and cost considerations in hyponatraemic patients needing hospitalisation.
    Althaus AE; Krapf R
    Swiss Med Wkly; 2018 Sep; 148():w14662. PubMed ID: 30378638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of Guillain-Barré syndrome in a tropical country: a Brazilian experience.
    Dourado ME; Félix RH; da Silva WK; Queiroz JW; Jeronimo SM
    Acta Neurol Scand; 2012 Jan; 125(1):47-53. PubMed ID: 21428966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy and mechanism of lymphoplasma exchange in the treatment of Guillain-Barre syndrome.
    Luo MC; Wang WF; Yin WF; Li Y; Li BJ; Duan WW; Zeng QM; Luo YB; Yang XS; Yang H
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):106-115. PubMed ID: 29096750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barre syndrome: a clinical study in King Chulalongkorn Memorial Hospital.
    Areeyapinan P; Phanthumchinda K
    J Med Assoc Thai; 2010 Oct; 93(10):1150-5. PubMed ID: 20973317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barre syndrome: Demographics, clinical profile & seasonal variation in a tertiary care centre of central India.
    Shrivastava M; Nehal S; Seema N
    Indian J Med Res; 2017 Feb; 145(2):203-208. PubMed ID: 28639596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignancy in Guillain-Barré syndrome: A twelve-year single-center study.
    Hiew FL; Rajabally YA
    J Neurol Sci; 2017 Apr; 375():275-278. PubMed ID: 28320147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early predictors of functional disability in Guillain-Barré Syndrome.
    Tunç A
    Acta Neurol Belg; 2019 Dec; 119(4):555-559. PubMed ID: 30963477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.